No it’s not a material event they paid 700 k the rule is inter testing it’s not material under 10 percent of overall market cap and this on July 31 was maybe 1/4 of one percent, acquisitions is 20 percent otherwise you need audits, that’s why Medisource and pantheon didn’t need audits it didn’t rise to that materiality, there are many degrees of materiality, but this one almost isn’t material as it is today so no again you are wrong.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links